Common Contracts
1 similar Study Agreement contracts
ContractStudy Agreement • November 11th, 2021
Amendment #1 to Clinical Trial Agreement Dodatek č. 1 ke smlouvě o klinickém hodnocení. This amendment (the “Amendment”) to the Clinical Study Agreement (the “Agreement”) by and among Krajská nemocnice T.Bati a.s., Havlíčkovo nábřeží 600, 762 75 Zlín, Registration number 27661989, registered at the Commercial Registry the Regional Court in Brno, section B, Insert 4437, represented by doc. MUDr. Michal Filip, Ph. D., Chairman of the Board and Ing. Martin Déva, member of the Board, (the “Institution”), , with an address at Havlíčkovo nábřeží 600, 762 75 Zlín (the “Investigator”), and ImmunoGen, Inc. with an address at 830 Winter Street, Waltham, MA 02451 (the “Sponsor”), with an effective date of 14 September 2020, in connection with Sponsor’s Protocol No. IMNG853-0416, is made effective on the Amendment Effective Date as defined below. Tento dodatek („Dodatek“) ke smlouvě o klinickém hodnocení („Smlouva“) uzavřené mezi stranami: Krajská nemocnice T. Bati, a. s., se sídlem Havlíčkovo
